The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 29, 2024

Filed:

Aug. 22, 2018
Applicants:

University Health Network, Toronto, CA;

The Hospital for Sick Children, Toronto, CA;

Inventors:

Gordon Keller, Toronto, CA;

Shinichiro Ogawa, Toronto, CA;

Anand Ghanekar, Toronto, CA;

Christine Bear, Toronto, CA;

Binita M. Kamath, Toronto, CA;

Mina Ogawa, Toronto, CA;

James Surapisitchat, Toronto, CA;

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 5/071 (2010.01); A61K 35/407 (2015.01);
U.S. Cl.
CPC ...
C12N 5/067 (2013.01); C12N 5/0679 (2013.01); A61K 35/407 (2013.01); C12N 2501/01 (2013.01); C12N 2501/115 (2013.01); C12N 2501/119 (2013.01); C12N 2501/12 (2013.01); C12N 2501/155 (2013.01); C12N 2501/16 (2013.01); C12N 2501/237 (2013.01); C12N 2501/415 (2013.01); C12N 2501/42 (2013.01); C12N 2501/724 (2013.01); C12N 2501/727 (2013.01); C12N 2501/999 (2013.01); C12N 2502/00 (2013.01); C12N 2502/14 (2013.01); C12N 2503/02 (2013.01); C12N 2506/02 (2013.01); C12N 2506/45 (2013.01);
Abstract

Methods for producing hepatocyte and/or cholangiocyte lineage cells from pluripotent stem cells, the method comprising (a) specifying the extended nodal agonist treated induced endodermal cell population to obtain a cell population comprising hepatocyte and/or cholangiocyte progenitors by contacting the extended nodal agonist treated induced endodermal cell population with specification media comprising a FGF agonist and a BMP4 agonist and/or active conjugates and/or fragments thereof; (b) inducing maturation, and optionally further lineage specification and/or expansion of the hepatocyte and/or cholangiocyte progenitors of the cell population to obtain a population comprising hepatocyte lineage cells such as hepatoblasts, hepatocytes and/or cholangiocytes, the inducing maturation step comprising generating aggregates of the cell population. Optionally, the method also comprises activating the cAMP pathway within the aggregates and forming co-aggregates.


Find Patent Forward Citations

Loading…